middle.news
How Race Oncology’s Discovery of Active Bisantrene Isomer Could Transform Cancer Care
9:09am on Tuesday 16th of September, 2025 AEST
•
Healthcare
Read Story
How Race Oncology’s Discovery of Active Bisantrene Isomer Could Transform Cancer Care
9:09am on Tuesday 16th of September, 2025 AEST
Key Points
Discovery of three photoisomers in bisantrene with distinct anticancer activities
Only the (E,E)-bisantrene isomer exhibits significant therapeutic effect
Three new patent applications filed covering composition, manufacture, and use
Potential 20-year composition of matter patent protection until 2045
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Racura Oncology (ASX:RAC)
OPEN ARTICLE